Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Monroy-Iglesias, Maria J."'
Autor:
Monroy-Iglesias MJ; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Russell B; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Crawley D; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Allen NE; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, UK., Travis RC; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Perez-Cornago A; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Van Hemelrijck M; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Beckmann K; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Cancer Research Institute, University of South Australia, Adelaide, Australia.
Publikováno v:
International journal of cancer [Int J Cancer] 2021 Feb 15; Vol. 148 (4), pp. 825-834. Date of Electronic Publication: 2020 Sep 11.
Autor:
Maria J. Monroy‐Iglesias, Beth Russell, Danielle Crawley, Naomi E. Allen, Ruth C. Travis, Aurora Perez‐Cornago, Mieke Van Hemelrijck, Kerri Beckmann
We investigated the association between metabolic syndrome (MetS) and its components and risk of prostate cancer (PCa) in a cohort of men enrolled in the UK Biobank. Our study cohort included 220 622 PCa‐free men with baseline measurements of trigl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c744d4e5adaf1d14a5034189e30f617
https://hdl.handle.net/11541.2/144694
https://hdl.handle.net/11541.2/144694